Peter Homberg is a partner in the Dentons Berlin office. He focuses on life sciences, IP, corporate law and M&A transactions in the life sciences and high-tech sector as well as in R&D and cooperation agreements, cross-border IP licensing and IP strategies. Furthermore, he has extensive experience providing legal advice on compliance issues. Additionally, he is the head of the European Cannabis sector group. Peter advises companies in the pharmaceutical, diagnostics, biotechnology, medical device and medical cannabis industries—from startups to large publicly listed companies and has broad transactional experience in Southeast Asia. Peter is member of the Licensing Executive Society (LES), the German Association for Intellectual Property and Copyright (GRUR), the German Institution for Arbitration (DIS) as well as the Pharma-Lizenz-Club Deutschland e.V. Furthermore, he is chairman of the board and heading of the Regulatory Working Group at the European Cannabis Association (ECA) and regularly holds lectures at seminars and conferences and a monthly deep-dive webinar on current topics of medical cannabis law and the German and international medical cannabis market. He is also the author of numerous professional articles and other publications regarding corporate or IP law in the field of life sciences.